The Novo Nordisk company is stopping the production of human insulin pen-type insulin syringes, affecting people with type 1 diabetes.
Călin Nicolescu
Health
Foto Pixabay
Always see our news on Google
People with type 1 diabetes who depend on human insulin made by Novo Nordisk will instead be given glass vials and syringes - said to be inconvenient and harder to use with the same precision. Novo Nordisk has already stopped supply in South Africa, where patients have had to switch to glass vials. Novo Nordisk's decision is linked to its favoring of the marketing of the slimming drugs Ozempic and Wegovy.
Sources
O companie farmaceutică ar fi oprit producţia de seringi cu insulină pentru a vinde produse de slăbit
Weight-loss drug firm accused of prioritising profits after halting insulin pen production
Novo Nordisk, compania producătoare de medicamente folosite pentru pierderea în greutate, acuzată că prioritizează profiturile după oprirea producției de stilouri cu insulină
Latest News
22:52
Dan Neculăescu supports human oversight of artificial intelligence and clear rules against abusive use
22:29
The U.S. Federal Reserve decided to maintain the benchmark interest rate at 3.75%-4%, despite persistent high inflation
22:14
Diana Stoica accuses PSD and AUR of blocking the Finance Minister’s hearing in Parliament
22:02
Cristela Georgescu accuses the proceedings in Călin Georgescu’s case of irregularities following the extension of his pretrial detention
21:54
Eurostat: Real per capita income rose by 0.1% in the EU in the second quarter of 2026, while the saving rate fell
See more news
NEWS ON THE SAME TOPICS
International
Germany will provide €400 million to maintain Sanofi’s insulin production and reduce the risk of shortages in Europe
IT&C knowledge
Novo collaborates with Anthropic to use artificial intelligence in the research and development of new medicines
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
